|
|
|
|
|
|
|
The Alzheimer's Association relies on the help of partners in the fight against this disease, and NARFE continues to demonstrate an outstanding commitment to the Association. Thanks to the support of partners such as NARFE and its members, the Association is the largest nonprofit funder of Alzheimer's research. Currently, we have committed $160 million to accelerating research advances in 21 countries, and as a catalyst and convener, the Association unites the world's leading researchers to drive scientific progress forward. Alzheimer's is an incredibly complex disease, but as you will see in this month's report, we continue to work toward methods of prevention, treatment and, one day, a cure.
|
|
|
Results of Alzheimer's drug study show promise
At the Alzheimer's Association International Conference® 2018 (AAIC®), the world's largest forum for the dementia research community, Eisai Co., Ltd and Biogen Inc. announced additional results of a Phase II clinical trial of a drug called BAN2401. Although the primary results of the study at 12 months were negative in December 2017, researchers reported positive results at 18 months on several secondary outcomes, including reduction of amyloid plaques and improvement of cognition and function. A larger confirmatory trial is needed. Learn more.
|
|
|
|
|
Treating high blood pressure may reduce dementia risk
Nearly 6,000 leading researchers, clinicians, investigators and care providers from 68 countries are met AAIC 2018 to share the latest study results, theories and discoveries. Results presented from the federally funded SPRINT MIND Study showed significant reductions in the risk of mild cognitive impairment (MCI) and the combination of MCI and dementia through aggressive lowering of systolic blood pressure. Learn more.
|
|
|
|
|
Pregnancy and reproductive history may be linked to dementia
Research from AAIC highlighted gender differences associated with dementia and Alzheimer's, including the first-ever large-scale study of reproductive history and dementia risk in women. The results suggested a link between dementia risk and number of children, number of miscarriages, age at first menstrual period and length of reproductive period. Separate research found a correlation between cumulative months of pregnancy and Alzheimer's risk. Learn more.
|
|
|
|
|
Link may exist between eye diseases and Alzheimer's
A new study suggests a possible connection between three degenerative eye diseases and Alzheimer's. Researchers report that of more than 3,800 study participants aged 65 and older, those with age-related macular degeneration, diabetic retinopathy or glaucoma had a 40 to 50 percent greater risk of Alzheimer's. The researchers suggest that primary care doctors seeing patients with these eye conditions should be more attentive to checking for possible dementia or memory loss. Learn more.
|
|
|
|
|
Learn about the brain with our interactive tour
Alzheimer's disease leads to nerve cell death and tissue loss throughout the brain. Over time, the brain shrinks dramatically, affecting nearly all its functions. Take our interactive Brain Tour to find out how the brain of someone with Alzheimer's differs from a healthy brain. Learn more.
|
|
|
|
|
Register for the NARFE Walk team
It's time to join the NARFE National Walk Team! Walk to End Alzheimer's® is the world's largest event to raise awareness and funds for Alzheimer's care, support and research, and it's an opportunity for you to join with NARFE members in your area who share your commitment to end this disease. Please help NARFE reach our Walk team goal of $100,000. Register today!
|
|
|
|
|
View Past Issues
|
|
|
|
|
NARFE Contributions to Advance Alzheimer's Research
NARFE 2018 GOAL $13 MILLION
|
|
|
|
24/7 Helpline: 1-800-272-3900
|
|
